| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.14 | 0.4 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |